Clinical Experience with Dofetilide in the Treatment of Patients with Atrial Fibrillation

Abstract

Dofetilide is a well-tolerated antiarrhythmic drug with a high conversion rate of AF to sinus rhythm. One third of patients maintained sinus rhythm at 1 year. Proarrhythmia can occur and initiation of therapy must be performed in-hospital.